Rapamycin antagonizes cyclosporin A- and tacrolimus (FK506)-mediated augmentation of linker for activation of T cell expression in T cells

International Immunology

Volumn 15, Issue 11, 2003, Pages 1369-1378

  Cho, Clifford S ^a   Chang, Zhen ^a   Elkahwaji, Johny ^a   Scheunemann, Tara L ^a   Manthei, Eric R ^a   Colburn, Matthew ^a   Knechtle, Stuart J ^a   Hamawy, Majed M ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Immunosuppression; Signaling; Transplantation

Indexed keywords

CELL PROTEIN; CYCLOSPORIN A; FK 506 BINDING PROTEIN; IMMUNOPHILIN; IMMUNOSUPPRESSIVE AGENT; LINKER FOR ACTIVATION OF T CELL; MEMBRANE PROTEIN; RAPAMYCIN; RNA; SIGNAL PEPTIDE; TACROLIMUS; UNCLASSIFIED DRUG;

ARTICLE; BINDING COMPETITION; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG INHIBITION; DRUG POTENCY; DRUG PROTEIN BINDING; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN STABILITY; REGULATORY MECHANISM; RNA ANALYSIS; RNA STABILITY; RNA TRANSLATION; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BASE SEQUENCE; CARRIER PROTEINS; CELL LINE, TUMOR; CYCLOSPORINE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE ACTIVATION; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; PHOSPHOPROTEINS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RNA, MESSENGER; SIGNAL TRANSDUCTION; SIROLIMUS; T-LYMPHOCYTES; TACROLIMUS;

EID: 0242720665     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/dxg138     Document Type: Article

References (68)

1. Denton, M. D., Magee, C. C. and Sayegh, M. H. 1999. Immunosuppressive strategies in transplantation. Lancet 353:1083.
2. Suthanthiran, M., Morris, R. E. and Strom, T. B. 1996. Immunosuppressants: cellular and molecular mechanisms of action. Am. J. Kidney Dis. 28:159.
3. Braun, F., Lorf, T. and Ringe, B. 1998. Update of current immunosuppressive drugs used in clinical organ transplantation. Transplant. Int. 11:77.
4. Mor, E., Yussim, A., Chodoff, L. and Schwartz, M. E. 1997. New immunosuppressive agents for maintenance therapy in organ transplantation. Focus on adverse effects. BioDrugs 8:469.
5. Liu, J., Farmer, J. D., Jr, Lane, W. S., Friedman, J., Weissman, I. and Schreiber, S. L. 1991. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66:807.
6. Fruman, D. A., Klee, C. B., Bierer, B. E. and Burakoff, S. J. 1992. Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A. Proc. Natl Acad. Sci. USA 89:3686.
7. Schreiber, S. L. 1992. Immunophilin-sensitive protein phosphatase action in cell signaling pathways. Cell 70:365.
8. Chan, A. C. and Shaw, A. S. 1996. Regulation of antigen receptor signal transduction by protein tyrosine kinases. Curr. Opin. Immunol. 8:394.
9. Kane, L. P., Lin, J. and Weiss, A. 2000. Signal transduction by the TCR for antigen. Curr. Opin. Immunol. 12:242.
10. van Leeuwen, J. E. and Samelson, L. E. 1999. T cell antigen-receptor signal transduction. Curr. Opin. Immunol. 11:242.
11. Northrop, J. P., Ullman, K. S. and Crabtree, G. R. 1993. Characterization of the nuclear and cytoplasmic components of the lymphoid-specific nuclear factor of activated T cells (NF-AT) complex. J. Biol. Chem. 268:2917.
12. ras and calcineurin synergize to regulate the nuclear factor of activated T cells. J. Exp. Med. 178:1517.
13. Shibasaki, F., Price, E. R., Milan, D. and McKeon, F. 1996. Role of kinases and the phosphatase calcineurin in the nuclear shuttling of transcription factor NF-AT4. Nature 382:370.
14. Chung, J., Kuo, C. J., Crabtree, G. R. and Blenis, J. 1992. Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases. Cell 69:1227.
15. Price, D. J., Grove, J. R., Calvo, V., Avruch, J. and Bierer, B. E. 1992. Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase. Science 257:973.
16. Powell, J. D., Lerner, C. G. and Schwartz, R. H. 1999. Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of co-stimulation. J. Immunol. 162:2775.
17. Wells, A. D., Li, X. C., Li, Y., Walsh, M. C., Zheng, X. X., Wu, Z., Nunez, G., Tang, A., Sayegh, M., Hancock, W. W., Strom, T. B. and Turka, L. A. 1999. Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance. Nat. Med. 5:1303.
18. Smiley, S. T., Csizmadia, V., Gao, W., Turka, L. A. and Hancock, W. W. 2000. Differential effects of cyclosporine A, methylprednisolone, mycophenolate, and rapamycin on CD154 induction and requirement for NFkappaB: implications for tolerance induction. Transplantation 70:415.
19. Zhang, W., Sloan-Lancaster, J., Kitchen, J., Trible, R. P. and Samelson, L. E. 1998. LAT: the ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activation. Cell 92:83.
20. Finco, T. S., Kadlecek, T., Zhang, W. G., Samelson, L. E. and Weiss, A. 1998. LAT is required for TCR-mediated activation of PLC gamma 1 and the Ras pathway. Immunity 9:617.
21. Zhang, W., Sommers, C. L., Burshtyn, D. N., Stebbins, C. C., DeJarnette, J. B., Trible, R. P., Grinberg, A., Tsay, H. C., Jacobs, H. M., Kessler, C. M., Long, E. O., Love, P. E. and Samelson, L. E. 1999. Essential role of LAT in T cell development. Immunity 10:323.
22. Bosselut, R., Zhang, W., Ashe, J. M., Kopacz, J. L., Samelson, L. E. and Singer, A. 1999. Association of the adaptor molecule LAT with CD4 and CD8 coreceptors identifies a new coreceptor function in T cell receptor signal transduction. J. Exp. Med. 190:1517.
23. Zhang, W., Irvin, B. J., Trible, R. P., Abraham, R. T. and Samelson, L. E. 1999. Functional analysis of LAT in TCR-mediated signaling pathways using a LAT-deficient Jurkat cell line. Int. Immunol. 11:943.
24. Tsuchida, M., Manthei, E. R., Knechtle, S. J. and Hamawy, M. M. 1999. CD28 ligation induces rapid tyrosine phosphorylation of the linker molecule LAT in the absence of Syk and Zap-70 tyrosine phosphorylation. Eur. J. Immunol. 29:2354.
25. Gibbins, J. M., Briddon, S., Shutes, A., van Vugt, M. J., van de Winkel, J. G., Saito, T. and Watson, S. P. 1998. The p85 subunit of phosphatidylinositol 3-kinase associates with the Fc receptor gamma-chain and linker for activator of T cells (LAT) in platelets stimulated by collagen and convulxin. J. Biol. Chem. 273:34437.
26. Qian, D. and Weiss, A. 1997. T cell antigen receptor signal transduction. Curr. Opin. Cell Biol. 9:205.
27. Su, B. and Karin, M. 1996. Mitogen-activated protein kinase cascades and regulation of gene expression. Curr. Opin. Immunol. 8:402.
28. Schaeffer, H. J. and Weber, M. J. 1999. Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol. Cell Biol. 19:2435.
29. Klee, C. B., Ren, H. and Wang, X. T. 1998. Regulation of the calmodulin-stimulated protein phosphatase, calcineurin. J. Biol. Chem. 273:13367.
30. 2+, calcineurin, and NF-AT. Cell 96:611.
31. Peters, D., Tsuchida, M., Manthei, E. R., Alam, T., Cho, C. S., Knechtle, S. J. and Hamawy, M. M. 2000. Potentiation of CD3-induced expression of the linker for activation of T cells (LAT) by the calcineurin inhibitors cyclosporin A and FK506. Blood 95:2733.
32. 2+. J. Immunol. 163:6640.
33. Hamawy, M. M., Mergenhagen, S. E. and Siraganian, R. P. 1993. Tyrosine phosphorylation of pp125FAK by the aggregation of high affinity immunoglobulin E receptors requires cell adherence. J. Biol. Chem. 268:6851.
34. Hamawy, M. M., Swaim, W. D., Minoguchi, K., de Feijter, A. W., Mergenhagen, S. E. and Siraganian, R. P. 1994. The aggregation of the high affinity IgE receptor induces tyrosine phosphorylation of paxillin, a focal adhesion protein. J. Immunol. 153:4655.
35. Hamawy, M. M., Swieter, M., Mergenhagen, S. E. and Siraganian, R. P. 1997. Reconstitution of high affinity IgE receptor-mediated secretion by transfecting protein tyrosine kinase pp125FAK. J. Biol. Chem. 272:30498.
36. Su, B., Jacinto, E., Hibi, M., Kallunki, T., Karin, M. and Ben-Neriah, Y. 1994. JNK is involved in signal integration during co-stimulation of T lymphocytes. Cell 77:727.
37. Werlen, G., Jacinto, E., Xia, Y. and Karin, M. 1998. Calcineurin preferentially synergizes with PKC-theta to activate JNK and IL-2 promoter in T lymphocytes. EMBO J. 17:3101.
38. 2+ release. Eur. J. Pharmacol. 381:51.
39. Dumont, F. J., Staruch, M. J., Fischer, P., Dasilva, C. and Camacho, R. 1998. Inhibition of T cell activation by pharmacologic disruption of the MEK1/ERK MAP kinase or calcineurin signaling pathways results in differential modulation of cytokine production. J. Immunol. 160:2579.
40. Li, B., Sehajpal, P. K., Khanna, A., Vlassara, H., Cerami, A., Stenzel, K. H. and Suthanthiran, M. 1991. Differential regulation of transforming growth factor beta and interleukin 2 genes in human T cells: demonstration by usage of novel competitor DNA constructs in the quantitative polymerase chain reaction. J. Exp. Med. 174:1259.
41. van der Pouw Kraan, T. C., Boeije, L. C., Troon, J. T., Rutschmann, S. K., Wijdenes, J. and Aarden, L. A. 1996. Human IL-13 production is negatively influenced by CD3 engagement. Enhancement of IL-13 production by cyclosporin A. J. Immunol. 156:1818.
42. Mascarell, L., Frey, J. R., Michel, F., Lefkovits, I. and Truffa-Bachi, P. 2000. Increased protein synthesis after T cell activation in presence of cyclosporin A. Transplantation 70:340.
43. Pedersen, S., Celis, J. E., Nielsen, J., Christiansen, J. and Nielsen, F. C. 1997. Distinct repression of translation by wortmannin and rapamycin. Eur. J. Biochem. 247:449.
44. Miyamoto, S. and Safer, B. 1999. Immunosuppressants FK506 and rapamycin have different effects on the biosynthesis of cytoplasmic actin during the early period of T cell activation. Biochem. J. 344:803.
45. Parker, D. C., Greiner, D. L., Phillips, N. E., Appel, M. C., Steele, A. W., Durie, F. H., Noelle, R. J., Mordes, J. P. and Rossini, A. A. 1995. Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand. Proc. Natl Acad. Sci. USA 92:9560.
46. Larsen, C. P., Alexander, D. Z., Hollenbaugh, D., Elwood, E. T., Ritchie, S. C., Aruffo, A., Hendrix, R. and Pearson, T. C. 1996. CD40-gp39 interactions play a critical role during allograft rejection. Suppression of allograft rejection by blockade of the CD40-gp39 pathway. Transplantation 61:4.
47. Larsen, C. P., Elwood, E. T., Alexander, D. Z., Ritchie, S. C., Hendrix, R., Tucker-Burden, C., Cho, H. R., Aruffo, A., Hollenbaugh, D., Linsley, P. S., Winn, K. J. and Pearson, T. C. 1996. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381:434.
48. + T cells, interferon-gamma, and CTLA4. J. Clin. Invest. 101:2446.
49. + T cell tolerance and linked suppression. J. Immunol. 163:4805.
50. Zheng, X. X., Li, Y., Li, X. C., Roy-Chaudhury, P., Nickerson, P., Tian, Y., Sayegh, M. H. and Strom, T. B. 1999. Blockade of CD40L/CD40 co-stimulatory pathway in a DST presensitization model of islet allograft leads to a state of allo-Ag specific tolerance and permits subsequent engraftment of donor strain islet or heart allografts. Transplant. Proc. 31:627.
51. Rossini, A. A., Mordes, J. P., Markees, T. G., Phillips, N. E., Gordon, E. J. and Greiner, D. L. 1999. Induction of islet transplantation tolerance using donor specific transfusion and anti-CD154 monoclonal antibody. Transplant. Proc. 31:629.
52. Cho, C. S., Hamawy, M. M. and Knechtle, S. J. 2000. CD40:CD154 ligand interactions and allograft rejection. Curr. Opin. Organ Transplant. 5:10.
53. Kirk, A. D., Harlan, D. M., Armstrong, N. N., Davis, T. A., Dong, Y., Gray, G. S., Hong, X., Thomas, D., Fechner, J. H. J. and Knechtle, S. J. 1997. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc. Natl Acad. Sci. USA 94:8789.
54. Kirk, A. D., Burkly, L. C., Batty, D. S., Baumgartner, R. E., Berning, J. D., Buchanan, K., Fechner, J. H., Jr, Germond, R. L., Kampen, R. L., Patterson, N. B., Swanson, S. J., Tadaki, D. K., TenHoor, C. N., White, L., Knechtle, S. J. and Harlan, D. M. 1999. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nat. Med. 5:686.
55. Pierson, R. N., III, Chang, A. C., Blum, M. G., Blair, K. S., Scott, M. A., Atkinson, J. B., Collins, B. J., Zhang, J. P., Thomas, D. W., Burkly, L. C. and Miller, G. G. 1999. Prolongation of primate cardiac allograft survival by treatment with anti-CD40 ligand (CD154) antibody. Transplantation 68:1800.
56. Kenyon, N. S., Chatzipetrou, M., Masetti, M., Ranuncoli, A., Oliveira, M., Wagner, J. L., Kirk, A. D., Harlan, D. M., Burkly, L. C. and Ricordi, C. 1999. Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154. Proc. Natl Acad. Sci. USA 96:8132.
57. Kenyon, N. S., Fernandez, L. A., Lehmann, R., Masetti, M., Ranuncoli, A., Chatzipetrou, M., Iaria, G., Han, D., Wagner, J. L., Ruiz, P., Berho, M., Inverardi, L., Alejandro, R., Mintz, D. H., Kirk, A. D., Harlan, D. M., Burkly, L. C. and Ricordi, C. 1999. Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154. Diabetes 48:1473.
58. Cho, C. S., Burkly, L. C., Fechner, J. H., Jr, Kirk, A. D., Oberley, T. D., Dong, Y., Brunner, K. G., Peters, D., TenHoor, C. N., Nadeau, K., Yagci, G., Ishido, N., Schultz, J. M., Tsuchida, M., Hamawy, M. M. and Knechtle, S. J. 2001. Successful conversion from conventional immunosuppression to anti-CD154 monoclonal antibody co-stimulatory molecule blockade in rhesus renal allograft recipients. Transplantation 72:587.
59. Li, Y., Zheng, X. X., Li, X. C., Zand, M. S. and Strom, T. B. 1998. Combined co-stimulation blockade plus rapamycin but not cyclosporine produces permanent engraftment. Transplantation 66:1387.
60. Li, Y., Li, X. C., Zheng, X. X., Wells, A. D., Turka, L. A. and Strom, T. B. 1999. Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance. Nat. Med. 5:1298.
61. Wells, A. D., Walsh, M. C., Sankaran, D. and Turka, L. A. 2000. T cell effector function and anergy avoidance are quantitatively linked to cell division. J. Immunol. 165:2432.
62. Jenkins, M. K., Chen, C. A., Jung, G., Mueller, D. L. and Schwartz, R. H. 1990. Inhibition of antigen-specific proliferation of type 1 murine T cell clones after stimulation with immobilized anti-CD3 monoclonal antibody. J. Immunol. 144:16.
63. Harding, F. A., McArthur, J. G., Gross, J. A., Raulet, D. H. and Allison, J. P. 1992, CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 356:607.
64. Sloan-Lancaster, J., Evavold, B. D. and Allen, P. M. 1993. Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells. Nature 363:156.
65. h2 cell clonal energy as a consequence of partial activation. J. Exp. Med. 180:1195.
66. McKay, D. B., Irie, H. Y., Hollander, G., Ferrara, J. L., Strom, T. B., Li, Y. and Burakoff, S. J. 1999. Antigen-induced unresponsiveness results in altered T cell signaling. J. Immunol. 163:6455.
67. Chau, L. A. and Madrenas, J. 1999. Phospho-LAT-independent activation of the ras-mitogen-activated protein kinase pathway: a differential recruitment model of TCR partial agonist signaling. J. Immunol. 163:1853.
68. Madrenas, J. 2000. Triggering of the T-cell receptor. Implications for transplantation. Graft 3:S3.